+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

US Home Diagnostics for Urinary Tract Infection Market Forecast to 2027 - COVID-19 Impact and Country Analysis By Form Type and Distribution Channel

  • ID: 5180723
  • Report
  • August 2020
  • Region: United States
  • 65 pages
  • The Insight Partners
UP TO OFF
until Jan 15th 2021
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories
  • Acon Laboratories, Inc.
  • Arkray Inc.
  • i-Health, Inc (AZO)
  • Pathnostics
  • Scanwell Health
  • MORE
The US home diagnostics for urinary tract infection market is expected to reach US$ 444.91 million by 2027 from US$ 267.44 million in 2019; it is expected to grow at a CAGR of 6.7% from 2020 to 2027.

The growth of the market is attributed to the key factors such as the growing UTI prevalence and increasing geriatric population. However, inaccuracy in the results of home UTI screening tests is the major factor hindering its market.

Advancements in the global healthcare sector and increasing emphasis on self care as well as preventive care lead to the emergence of home-based diagnostics. The medical device manufacturers focus on the implementation of new designs and prototypes to offer significant care to patients at home. Home diagnostics confer improved patient care and experience and superior patient convenience, and incur lower cost. Moreover, the introduction of advanced diagnostics products for UTI detection is also projected to increase the adoption of home diagnostics products in the coming years. Further, the increasing emphasis of government authorities to encourage home care provides significant opportunities for the growth of the market players. As per the American Urological Association, November is Bladder Health Awareness Month that serves as a reminder to Americans to gain the knowledge about common bladder health conditions and proactively take initiatives to take care of bladder health. National Health Observance, the Urology Care Foundation sponsored by the US Department of Health and Human Services, is the world's leading nonprofit urological health foundation.

Based on form type, the US home diagnostics for urinary tract infection market is segmented into dipsticks, cups, dipslides, cassettes, and others. In 2019, the dipsticks segment held the largest share of the market and is anticipated to register the highest CAGR during the forecast period. Based on distribution channel, the US home diagnostics for urinary tract infection market is segmented into retail pharmacies and drug stores, supermarkets/hypermarkets, and online pharmacies. The retail pharmacies and drug stores segment held the largest share of the market in 2019. The market for online pharmacies is anticipated to grow at the fastest CAGR during the forecast period.

A few of the major primary and secondary sources referred to while preparing this report on the US home diagnostics for urinary tract infection market are Chronic Kidney Disease (CKD), National Statistics Institute (NSI), Food and Drug Administration (FDA), and Centers for Disease Control and Prevention (CDC).

Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the US home diagnostics for urinary tract infection market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the US home diagnostics for urinary tract infection market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Acon Laboratories, Inc.
  • Arkray Inc.
  • i-Health, Inc (AZO)
  • Pathnostics
  • Scanwell Health
  • MORE
1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 US Home Diagnostics for Urinary Tract Infection Market - By Form Type
1.3.2 US Home Diagnostics for Urinary Tract Infection Market - By Distribution Channel
1.3.3 US Home Diagnostics for Urinary Tract Infection Market - By Country

2. Home Diagnostic for Urinary Tract Infection Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Home Diagnostics for Urinary Tract Infection Market - Market Landscape
4.1 Overview
4.2 US PEST Analysis
4.3 Expert Opinion

5. Home Diagnostics for Urinary Tract Infection Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Urinary Tract Infections
5.1.2 Aging Population
5.2 Market Restraints
5.2.1 Inaccuracy Of UTI Home Screening Test
5.3 Market Opportunities
5.3.1 Encouragement for Home Diagnostics
5.4 Future Trends
5.4.1 Utilization of Advanced Computing Technologies for Urine Diagnostics
5.5 Impact Analysis

6. Home Diagnostics for Urinary Tract Infection Market - US Analysis
6.1 US Home Diagnostics for Urinary Tract Infection Market Revenue Forecast and Analysis
6.2 Market Positioning of Key Players

7. US Home Diagnostics for Urinary Tract Infection Market Analysis - By Form Type
7.1 Overview
7.2 Home Diagnostics for Urinary Tract Infection Market Revenue Share, by Form Type (2019 and 2027)
7.3 Dipsticks
7.3.1 Overview
7.3.2 Dipsticks: Home Diagnostics for Urinary Tract Infection Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Cup
7.4.1 Overview
7.4.2 Cup: Home Diagnostics for Urinary Tract Infection Market - Revenue and Forecast to 2027 (US$ Million)
7.5 DipSlide
7.5.1 Overview
7.5.2 DipSlide: Home Diagnostics for Urinary Tract Infection Market - Revenue and Forecast to 2027 (US$ Million)
7.6 Cassette
7.6.1 Overview
7.6.2 Cassette: Home Diagnostics for Urinary Tract Infection Market - Revenue and Forecast to 2027 (US$ Million)
7.7 Other Form Types
7.7.1 Overview
7.7.2 Other Form Types: Home Diagnostics for Urinary Tract Infection Market - Revenue and Forecast to 2027 (US$ Million)

8. US Home Diagnostics for Urinary Tract Infection Market Analysis - By Distribution Channel
8.1 Overview
8.2 Home Diagnostics for Urinary Tract Infection Market Revenue Share, by Distribution Channel (2019 and 2027)
8.3 Retail Pharmacies & Drug Store
8.3.1 Overview
8.3.2 Retail Pharmacies: Home Diagnostics for Urinary Tract Infection Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Supermarket/ Hypermarket
8.4.1 Overview
8.4.2 Supermarket/ Hypermarket: Home Diagnostics for Urinary Tract Infection Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Online Pharmacies
8.5.1 Overview
8.5.2 Online Pharmacies: Home Diagnostics for Urinary Tract Infection Market - Revenue and Forecast to 2027 (US$ Million)

9. Impact of COVID-19 Pandemic on US Home Diagnostics for Urinary Tract Infection Market
9.1 US: Impact Assessment of COVID-19 Pandemic

10. Home Diagnostics for Urinary Tract Infection Market -Industry Landscape
10.1 Overview
10.2 Growth Strategies Done by the Companies in the Market, (%)
10.3 Organic Growth Strategies

11. Company Profiles
11.1 Pathnostics.
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 i-Health, Inc.
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 F. HOFFMANN-LA ROCHE LTD
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 ACON Laboratories, Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 ARKRAY
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 BD
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 ABBOTT
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 AytuBioScience, Inc. (Innovus Pharmaceuticals, Inc)
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Teco Diagnostics
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Scanwell Health
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments

12. Appendix
12.1 Glossary of Terms
Note: Product cover images may vary from those shown
3 of 3
  • i-Health, Inc (AZO)
  • F. Hoffmann-La Roche AG (Roche Holding AG)
  • Acon Laboratories, Inc.
  • Becton Dickinson and Company
  • Arkray Inc.
  • Pathnostics
  • Abbott Laboratories
  • Aytu BioScience, Inc. (Innovus Pharmaceuticals, Inc)
  • Teco Diagnostics
  • Scanwell Health
Note: Product cover images may vary from those shown
Adroll
adroll